Shares of Recro Pharma, Inc. (REPH) have traded between $5.54 – 19. The next earnings date is set for Feb 18, 2020. Let’s see how its prospects are shaping up.

What does Recro Pharma, Inc.(REPH) do?

Recro Pharma, Inc. is a pharmaceutical company, which engages in the research and development of non-opioid therapeutics for the treatment of acute post operative pain. It operates through the Acute Care, and Contract Development and Manufacturing (CDMO) business segment. The Acute Care segment focuses on developing innovative products for hospital and related settings. The CDMO segment leverages the company’s formulation expertise to develop and manufacture pharmaceutical products using the company’s proprietary delivery technologies for commercial partners who commercialize or plan to commercialize these products. Its products include Meloxicam, Dexmedetomidine, and Fadolmidine. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Malvern, PA.

REPH Insider Trading Insight

On 2019-05-17, Ajdler Arnaud Dir purchased 40,000 shares of REPH. That represents a value of $1,112,501. Not to be outdone, on 2019-05-13, Henwood Geraldine S – Sale+OE sold144,806 shares of REPH. These insiders are clearly in the know because they work closely with the company.

The UAL Consensus Price Target

The mean recommendation of United Airlines Holdings, Inc. from top Wall Street analysts is a Strong Buy. That is based on 8 analysts who work on the Street. Based on 8 analysts offering 12 month price targets for United Continental in the last 3 months. The average price target is $111.57 with a high forecast of $125.00 and a low forecast of $100.00. The average price target represents a 26.37% increase from the last price of $88.29. Last week, several articles were published in financial papers about UAL and 39% Bearish while 61% Bullish.

UAL Intraday Trading

UAL is due to report earnings on Jan 21, 2020. In the last year the price has ranged from 77.02 – 96.03. Recently, Corvi Carolyn sold 1,016 shares of UAL. He is a $94,270 shareholder in UAL.

Looking for stocks similar to REPH and UAL?

Here are some stocks to consider: